Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center, Dose-Escalation Study, to Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta® in OPMD Patients

NCT02015481 is registered in ClinicalTrials.gov with Bioblast Pharma Ltd. as lead sponsor.

NCT NCT02015481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02015481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center, Dose-Escalation Study, to Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta® in OPMD Patients
Lead sponsor
Bioblast Pharma Ltd.
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2014
Completion date
April 30, 2016
Enrollment
25 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

oculopharyngeal muscular dystrophy